Stock listing
NASDAQ:ANTX AN2 Therapeutics, Inc. Stock
Home listing (NASDAQ) of AN2 Therapeutics, Inc.
Follow AN2 Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:ANTX
$5.08 USD +0.13 (+2.6%)
Close on Nov 20, 2026
- Day range
- $4.99 – $5.49 USDNov 20, 2026
- Volume
- 332,710 sharesNov 20, 2026
- Market cap
- $192.8M USDAt the close on Nov 20, 2026 · price × 37.94M shares outstanding
- 52-week range
- $1.00 – $7.19 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $1.33M USDMedian day 240,355 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ANTX · Home | $5.08 USD | +0.13 (+2.6%) | 332,710 | $5.13 | $5.49 | $4.99 | $4.95 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:ANTX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $5.08 | +0.13 | +2.6% | $5.13 | $5.49 | $4.99 | 332,710 | |
| $4.95 | +0.72 | +17.0% | $4.40 | $5.32 | $4.23 | 967,421 | |
| $4.23 | -0.24 | -5.4% | $4.50 | $4.60 | $3.915 | 285,651 | |
| $4.47 | -0.08 | -1.8% | $4.51 | $4.70 | $4.365 | 246,860 | |
| $4.55 | +0.11 | +2.5% | $4.42 | $4.58 | $4.25 | 205,686 | |
| $4.44 | -0.02 | -0.4% | $4.48 | $4.75 | $4.34 | 186,344 | |
| $4.46 | +0.13 | +3.0% | $4.40 | $4.747 | $4.277 | 197,630 | |
| $4.33 | +0.33 | +8.3% | $3.99 | $4.505 | $3.93 | 271,603 | |
| $4.00 | 0.00 | 0.0% | $4.06 | $4.13 | $3.97 | 496,679 | |
| $4.00 | +0.045 | +1.1% | $3.99 | $4.11 | $3.90 | 240,355 | |
| $3.955 | -0.295 | -6.9% | $4.22 | $4.255 | $3.82 | 152,967 | |
| $4.25 | +0.07 | +1.7% | $4.22 | $4.31 | $4.10 | 131,826 | |
| $4.18 | -0.17 | -3.9% | $4.38 | $4.55 | $4.10 | 160,400 | |
| $4.35 | -0.18 | -4.0% | $4.54 | $4.64 | $4.241 | 299,604 | |
| $4.53 | -0.16 | -3.4% | $4.66 | $4.76 | $4.31 | 284,722 | |
| $4.69 | +0.17 | +3.8% | $4.57 | $4.90 | $4.53 | 555,792 | |
| $4.52 | +0.66 | +17.1% | $3.86 | $4.60 | $3.85 | 545,417 | |
| $3.86 | +0.23 | +6.3% | $3.61 | $3.89 | $3.54 | 239,623 | |
| $3.63 | +0.08 | +2.3% | $3.55 | $3.70 | $3.50 | 196,183 | |
| $3.55 | -0.09 | -2.5% | $3.61 | $3.66 | $3.47 | 124,439 | |
| $3.64 | +0.04 | +1.1% | $3.57 | $3.72 | $3.521 | 95,191 | |
| $3.60 | +0.04 | +1.1% | $3.58 | $3.78 | $3.57 | 177,367 | |
| $3.56 | +0.19 | +5.6% | $3.38 | $3.59 | $3.36 | 129,744 | |
| $3.37 | -0.01 | -0.3% | $3.39 | $3.46 | $3.21 | 330,870 | |
| $3.38 | -0.22 | -6.1% | $3.60 | $3.62 | $3.30 | 281,730 | |
| $3.60 | +0.06 | +1.7% | $3.50 | $3.69 | $3.50 | 295,943 | |
| $3.54 | -0.06 | -1.7% | $3.55 | $3.73 | $3.33 | 431,025 | |
| $3.60 | -0.70 | -16.3% | $4.30 | $4.32 | $3.59 | 515,050 | |
| $4.30 | -0.10 | -2.3% | $4.41 | $4.41 | $4.24 | 298,465 | |
| $4.40 | -0.28 | -6.0% | $4.65 | $4.67 | $4.26 | 442,134 | |
| $4.68 | -0.17 | -3.5% | $4.77 | $4.86 | $4.43 | 427,826 | |
| $4.85 | -0.22 | -4.3% | $5.02 | $5.06 | $4.695 | 365,253 | |
| $5.07 | -0.54 | -9.6% | $5.39 | $5.60 | $5.005 | 318,215 | |
| $5.61 | -0.10 | -1.8% | $5.69 | $5.86 | $5.50 | 299,949 | |
| $5.71 | +0.09 | +1.6% | $5.64 | $5.99 | $5.51 | 451,333 | |
| $5.62 | +0.30 | +5.6% | $5.29 | $5.73 | $5.155 | 509,439 | |
| $5.32 | +0.23 | +4.5% | $5.07 | $5.35 | $5.00 | 199,204 | |
| $5.09 | +0.08 | +1.6% | $4.99 | $5.20 | $4.76 | 178,839 | |
| $5.01 | +0.13 | +2.7% | $4.89 | $5.17 | $4.67 | 318,456 | |
| $4.88 | -0.01 | -0.2% | $4.91 | $4.95 | $4.71 | 155,127 | |
| $4.89 | +0.06 | +1.2% | $4.77 | $5.06 | $4.72 | 258,937 | |
| $4.83 | 0.00 | 0.0% | $4.86 | $4.95 | $4.67 | 306,158 | |
| $4.83 | -0.13 | -2.6% | $5.00 | $5.05 | $4.70 | 191,680 | |
| $4.96 | -0.09 | -1.8% | $5.06 | $5.25 | $4.92 | 305,221 | |
| $5.05 | +0.15 | +3.1% | $4.89 | $5.15 | $4.80 | 670,954 | |
| $4.90 | -0.44 | -8.2% | $5.39 | $5.47 | $4.88 | 204,494 | |
| $5.34 | -0.02 | -0.4% | $5.38 | $5.44 | $5.295 | 146,046 | |
| $5.36 | -0.10 | -1.8% | $5.43 | $5.50 | $5.20 | 156,797 | |
| $5.46 | +0.05 | +0.9% | $5.43 | $5.645 | $5.34 | 221,486 | |
| $5.41 | -0.28 | -4.9% | $5.70 | $5.78 | $5.40 | 103,538 | |
| $5.69 | -0.04 | -0.7% | $5.56 | $5.88 | $5.54 | 222,312 | |
| $5.73 | -0.25 | -4.2% | $5.98 | $6.125 | $5.605 | 175,804 | |
| $5.98 | +0.09 | +1.5% | $6.00 | $6.06 | $5.76 | 335,287 | |
| $5.89 | -0.06 | -1.0% | $5.97 | $6.06 | $5.85 | 77,182 | |
| $5.95 | 0.00 | 0.0% | $6.05 | $6.20 | $5.79 | 199,660 | |
| $5.95 | +0.47 | +8.6% | $5.46 | $6.00 | $5.46 | 353,561 | |
| $5.48 | -0.07 | -1.3% | $5.53 | $5.67 | $5.40 | 215,423 | |
| $5.55 | -0.03 | -0.5% | $5.58 | $5.645 | $5.40 | 124,021 | |
| $5.58 | -0.16 | -2.8% | $5.67 | $5.78 | $5.40 | 240,866 | |
| $5.74 | +0.21 | +3.8% | $5.46 | $5.79 | $5.46 | 204,041 | |
| $5.53 | -0.13 | -2.3% | $5.66 | $5.85 | $5.50 | 287,524 | |
| $5.66 | +0.03 | +0.5% | $5.67 | $5.80 | $5.60 | 217,706 | |
| $5.63 | -0.18 | -3.1% | $5.82 | $5.82 | $5.59 | 171,420 | |
| $5.81 | +0.02 | +0.3% | $5.84 | $5.89 | $5.50 | 225,449 | |
| $5.79 | -0.17 | -2.9% | $5.98 | $6.13 | $5.72 | 195,335 |
- Ticker
- NASDAQ:ANTX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 20, 2026
AN2 Therapeutics to Participate in 9th Annual Evercore Healthcare Conference
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 50 slides
Latest news
AN2 Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business and Scientific Highlights
Nov 9, 2026
Closed $4.00 (0.0%) on Nov 9, 2026
AN2 Therapeutics to Present at Jefferies Global Healthcare Conference in London
Nov 4, 2026
Closed $3.96 (-6.9%) on Nov 5, 2026
AN2 Therapeutics Advances Pipeline With Development Candidate Nomination for Hypophosphatasia (HPP)
Nov 4, 2026
Closed $4.25 (+1.7%) on Nov 4, 2026
AN2 Therapeutics Receives U.S. FDA IND Clearance to Proceed with Planned Phase 2 Global Study of Oral Epetraborole in Polycythemia Vera
Nov 2, 2026
Closed $4.35 (-4.0%) on Nov 2, 2026
AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(c)(4)
Oct 23, 2026
Closed $3.63 (+2.3%) on Oct 26, 2026
AN2 Therapeutics to Present Phase 2 Design for Epetraborole in Polycythemia Vera at the 18th International Congress on Myeloproliferative Neoplasms
Oct 21, 2026
Closed $3.60 (+1.1%) on Oct 21, 2026
AN2 Therapeutics to Participate at Upcoming Investor Conferences
Oct 20, 2026
Closed $3.60 (+1.1%) on Oct 21, 2026
AN2 Therapeutics Announces Extension of Funding for Tuberculosis Research Collaboration with GSK
Sep 28, 2026
Closed $5.01 (+2.7%) on Sep 28, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 50 slides · September 2026
Corporate Update (March 2026)
Corporate update · 17 slides · Mar 4, 2026
Investor Presentation (June 2025)
Investor deck · 40 slides · Jun 11, 2025
AN2 Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 23 in the last 12 months · 62 in all · newest Nov 20, 2026 · oldest 2022
- Decks
- 3 decks · latest September 2026
Where AN2 Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ANTX · Home listing · This page | NASDAQ | United States | USD |
| BOATS:ANTX | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about AN2 Therapeutics, Inc.